Abstract:Background: Apelin-13 has been found to have protective effects on many neurological diseases, including cerebral ischemia. However, whether Apelin-13 acts on blood-brain barrier (BBB) disruption following cerebral ischemia is largely unknown. Aquaporin-4 (AQP4) has a close link with BBB due to the high concentration in astrocyte foot processes and regulation of astrocytes function. Here, we aimed to test Apelin-13's effects on ischemic BBB injury and examine whether the effects were dependent on AQP4. Methods: We detected the expression of AQP4 induced by Apelin-13 injection at 1, 3, and 7 days after middle cerebral artery occlusion. Meanwhile, we examined the effects of Apelin-13 on neurological function, infarct volume, and BBB disruption owing to cerebral ischemia in wild type mice, and tested whether such effects were AQP4 dependent by using AQP4 knock-out mice. Furthermore, we assessed the possible signal transduction pathways activated by Apelin-13 to regulate AQP4 expression via astrocyte cultures. Results: It was found that Apelin-13 highly increased AQP4 expression as well as reduced neurological scores and infarct volume. Importantly, Apelin-13 played a role of BBB protection in both types of mice by reducing BBB permeability, increased vascular endothelial growth factor, upregulated endothelial nitric oxide synthase, and downregulated inducible NOS. In morphology, we demonstrated Apelin-13 suppressed tight junction opening and endothelial cell swelling via electron microscopy detection. Meanwhile, Apelin-13 also alleviated apoptosis of astrocytes and promoted angiogenesis. Interestingly, effects of AQP4 on neurological function and infarct volume varied with time course, while AQP4 elicited protective effects on BBB at all time points. Statistical analysis of 2-way analysis of variance with replication indicated that AQP4 was required for these effects. In addition, Apelin-13 upregulated phosphorylation of extracellular signal-regulated kinase (ERK) and Akt as well as AQP4 protein in cultured astrocytes. The latter was inhibited by ERK and phosphatidylinositol 3'-kinase (PI3K) inhibitors. Conclusion: Our data suggest that Apelin-13 protects BBB from disruption after cerebral ischemia both morphologically and functionally, which is highly associated with the increased levels of AQP4, possibly through the activation of ERK and PI3K/Akt pathways. This study provides double targets to protection of ischemic BBB damage, which can present new insights to drugs development.

Apelin supports primary rat retinal Müller cells under chemical hypoxia and glucose deprivation.

Apelin Protects Primary Rat Retinal Pericytes from Chemical Hypoxia-Induced Apoptosis

Apelin-13 Regulates Proliferation, Migration and Survival of Retinal Müller Cells under Hypoxia.

Apelin protects heart against ischemia/reperfusion injury in rat

Apelin-13 inhibits hypoxia-induced retinal Müller cell apoptosis by regulating YAP entry into the nucleus

The Role of Apelin in the Retina of Diabetic Rats

Apelin induces the proliferation, migration and expression of cytoskeleton and tight junction proteins in human RPE cells via PI-3K/Akt and MAPK/Erk signaling pathways.

Protective effect of Apelin-13 on oxygen and glucose deprivation induced-damage in retinal ganglion cells cultured in vitro

Apelin-13 Induces Proliferation, Migration, and Collagen I Mrna Expression in Human RPE Cells Via PI3K/Akt and MEK/Erk Signaling Pathways.

Apelin Induces the Proliferation, Migration and Expression of Cytoskeleton and Tight Junction Proteins in Human RPE Cells Via PI-3K/Akt and MAPK/Erk Signaling Pathways

Multiple Roles of Apelin/apj System in Eye Diseases.

Effects of Apelin on the Fibrosis of Retinal Tissues and Müller Cells in Diabetes Retinopathy Through the JAK2/STAT3 Signalling Pathway.

Apelin in Plasma and Vitreous and in Fibrovascular Retinal Membranes of Patients with Proliferative Diabetic Retinopathy.

The Protective Role of Apelin in the Early Stages of Diabetic Retinopathy

The Role of Apelin/APJ in a Mouse Model of Oxygen-induced Retinopathy

GW24-e3625 Effects of apelin on the phosphodiesterase 1 expression and oxidative stress levels in mouse kidney fibroblast cells

Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4

Apelin-13 is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema Via PI-3K/Akt and MAPK/Erk Signaling Pathways

Apelin-36, a Potent Peptide, Protects Against Ischemic Brain Injury by Activating the PI3K/Akt Pathway

Apelin-13 Protects the Heart Against Ischemia-Reperfusion Injury Through Inhibition of Er-Dependent Apoptotic Pathways in A Time-Dependent Fashion

Apelin Ameliorates High Glucose-Induced Downregulation of Connexin 43 via AMPK-Dependent Pathway in Neonatal Rat Cardiomyocytes